{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:21:38Z","timestamp":1791044498845,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI075443"],"award-info":[{"award-number":["U01 AI075443"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI104579"],"award-info":[{"award-number":["R01AI104579"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174187","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T22:59:34Z","timestamp":1490137174000},"page":"e0174187","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes"],"prefix":"10.1371","volume":"12","author":[{"given":"Yongfeng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Garcia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-3517","authenticated-orcid":false,"given":"James D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"ref1","article-title":"handbook for epidemiologists, clinicians,and laboratory workers","year":"1998"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"MD Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"ref3","article-title":"A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin","author":"SE Maslanka","year":"2015","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the Clostridial neurotxins","volume":"291","author":"DB Lacy","year":"1999","journal-title":"J Mol Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"JR Barash","year":"2014","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1699-0463.1960.tb04741.x","article-title":"Preliminary report on the isolation of an apparently new type of CI. botulinum","volume":"48","author":"V Moller","year":"1960","journal-title":"Acta Pathol Microbiol Scand"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JB.4.5.541-553.1919","article-title":"The Occurrence of Bacillus botulinus in Nature","volume":"4","author":"GS Burke","year":"1919","journal-title":"J Bacteriol"},{"key":"ref8","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","volume":"364","author":"KK Hill","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among Botulinum Neurotoxin-producing clostridial strains","volume":"189","author":"KK Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/AEM.03109-09","article-title":"Sequence diversity of genes encoding botulinum neurotoxin type F","volume":"76","author":"BH Raphael","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"TJ Smith","year":"2005","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"SS Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref13","first-page":"473","article-title":"Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects","author":"DR Franz","year":"1993"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin","volume":"69","author":"RE Black","year":"1980","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/clinids\/23.2.337","article-title":"Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E origin in Egypt","volume":"23","author":"RG Hibbs","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref16","first-page":"477","article-title":"Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects","author":"SS Arnon","year":"1993"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa051926","article-title":"Human botulism immune globulin for the treatment of infant botulism","volume":"354","author":"SS Arnon","year":"2006","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1542\/peds.2006-0646","article-title":"Creation and development of the public service orphan drug Human Botulism Immune Globulin","volume":"119","author":"SS Arnon","year":"2007","journal-title":"Pediatrics"},{"key":"ref19","unstructured":"(2013) Full prescribing information: Botulism Antitoxin Heptavalent (A, B, C,D, E, F, G)\u2014(Equine)."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/cid\/cir550","article-title":"Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin","volume":"53","author":"RP Fagan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1128\/AAC.02830-14","article-title":"Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A","volume":"58","author":"SU Nayak","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ab.2012.08.005","article-title":"Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein","volume":"430","author":"Q Meng","year":"2012","journal-title":"Anal Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ab.2011.09.030","article-title":"Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein","volume":"421","author":"Q Meng","year":"2012","journal-title":"Anal Biochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e0135306","DOI":"10.1371\/journal.pone.0135306","article-title":"Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype\/A Inhibit Catalytic Activity","volume":"10","author":"Y Fan","year":"2015","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3390\/toxins7093405","article-title":"Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype\/B","volume":"7","author":"Y Fan","year":"2015","journal-title":"Toxins (Basel)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jmb.2010.01.070","article-title":"A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region","volume":"397","author":"J Dong","year":"2010","journal-title":"J Mol Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2005.06.003","article-title":"Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A","volume":"351","author":"A Razai","year":"2005","journal-title":"J Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/infdis\/jiv770","article-title":"Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H","volume":"213","author":"Y Fan","year":"2016","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","article-title":"Multiple sequence alignment with hierarchical clustering","volume":"16","author":"F Corpet","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"X Robert","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/protein\/gzq111","article-title":"Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin","volume":"24","author":"C Garcia-Rodriguez","year":"2011","journal-title":"Protein Eng Des Sel"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt1269","article-title":"Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin","volume":"25","author":"C Garcia-Rodriguez","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/protein\/gzv067","article-title":"Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma","volume":"29","author":"I Grossman","year":"2016","journal-title":"Protein Eng Des Sel"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e12237","DOI":"10.1371\/journal.pone.0012237","article-title":"Extraction of BoNT\/A, \/B, \/E, and \/F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS","volume":"5","author":"SR Kalb","year":"2010","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T06:06:41Z","timestamp":1601791601000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174187"}},"subtitle":[],"editor":[{"given":"Mitchell","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174187","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}